New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors

被引：22

作者：

Cimetière, B ^{[1
]}

Dubuffet, T ^{[1
]}

Landras, C ^{[1
]}

Descombes, JJ ^{[1
]}

Simonet, S ^{[1
]}

Verbeuren, TJ ^{[1
]}

Lavielle, G ^{[1
]}

机构：

[1] Inst Rech Servier, Ctr Rech, F-78290 Croissy Sur Seine, France

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 11期

关键词：

D O I：

10.1016/S0960-894X(98)00221-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A pyridine group was linked to the tetrahydronaphthalene moiety of the derivatives described in the preceding paper, to afford new combined thromboxane receptor (TP-receptor) antagonists and synthase inhibitors. The most interesting compound Lf inhibits TXA2 synthase with an IC50 value of 0.64 mu M and the aggregation of human platelets with an IC50 value of 0.063 mu M and shows a long duration of action in different species after oral administration. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：1381 / 1386

页数：6

共 50 条

[21] RENAL EFFECTS OF THROMBOXANE SYNTHESIS INHIBITORS AND RECEPTOR ANTAGONISTS
PATRONO, C
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (01) : 143 - 143
[22] Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors
Rolin, S
Dogne, JM
Vastersaegher, C
Hanson, J
Masereel, B
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2004, 74 (1-4) : 75 - 86
[23] THROMBOXANE SYNTHASE INHIBITION COMBINED WITH THROMBOXANE RECEPTOR BLOCKADE - A STEP FORWARD IN ANTITHROMBOTIC STRATEGY
GRESELE, P
VANHOUTTE, E
ARNOUT, J
DECKMYN, H
VERMYLEN, J
THROMBOSIS AND HAEMOSTASIS, 1984, 52 (03) : 364 - 364
[24] ASSAY OF THROMBOXANE A SYNTHASE INHIBITORS
TAI, HH
METHODS IN ENZYMOLOGY, 1982, 86 : 110 - 113
[25] SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF COMBINED THROMBOXANE RECEPTOR ANTAGONIST THROMBOXANE SYNTHASE INHIBITORS - PYRIDINE-CONTAINING AMINO-PROSTANOIDS
CAMPBELL, IB
COLLINGTON, EW
FINCH, H
HAYES, R
LUMLEY, P
MILLS, K
ROBERTSON, GM
WHARTON, K
WATTS, IS
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (12) : 695 - 698
[26] Potent thromboxane receptor antagonists
Lloyd, AW
DRUG DISCOVERY TODAY, 1998, 3 (09) : 425 - 425
[27] CORRECTION OF ISCHEMIC BRAIN ACIDOSIS WITH A NOVEL THROMBOXANE RECEPTOR ANTAGONIST COMBINED WITH A THROMBOXANE SYNTHASE INHIBITOR
PETTIGREW, LC
HAZLE, JD
GUTIERREZ, G
ANNALS OF NEUROLOGY, 1990, 28 (02) : 223 - 224
[28] IMMUNOHISTOCHEMICAL LOCALIZATION OF THROMBOXANE RECEPTOR AND THROMBOXANE SYNTHASE IN RAT TESTIS
TAKAHASHI, N
TAKEUCHI, K
ABE, T
MURAKAMI, K
YAMAGUCHI, M
ABE, K
ENDOCRINOLOGY, 1995, 136 (09) : 4143 - 4146
[29] ROLE OF PROAGGREGATORY AND ANTIAGGREGATORY PROSTAGLANDINS IN HEMOSTASIS - STUDIES WITH COMBINED THROMBOXANE SYNTHASE INHIBITION AND THROMBOXANE RECEPTOR ANTAGONISM
GRESELE, P
ARNOUT, J
DECKMYN, H
HUYBRECHTS, E
PIETERS, G
VERMYLEN, J
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (05) : 1435 - 1445
[30] THROMBOXANE-A2 SYNTHETASE INHIBITORS .2. SYNTHESES AND ACTIVITIES OF TETRAHYDRONAPHTHALENE AND INDAN DERIVATIVES
KANAO, M
WATANABE, Y
KIMURA, Y
SAEGUSA, J
YAMAMOTO, K
KANNO, H
KANAYA, N
KUBO, H
ASHIDA, S
ISHIKAWA, F
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (06) : 1326 - 1334

← 1 2 3 4 5 →